JAK inhibitors (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JAK inhibitors (unspecified), covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica